Atopic Dermatitis Clinical Trials
A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 228 clinical trials
A Study to Assess the Efficacy and Safety of Ruxolitinib Cream in Children With Atopic Dermatitis (TRuE-AD3)
The purpose of the study is to assess the efficacy and safety of ruxolitinib cream in children with Atopic Dermatitis. This is a randomized, double-blind, Vehicle Controlled study
- 0 views
- 11 May, 2022
- 20 locations
Eczema (Atopic Dermatitis)
ITCHY OR SENSITIVE SKIN? Consider a clinical research study for eczema (atopic dermatitis).Insurance is not needed to participate in this study.
- 48 views
- 17 Nov, 2021
- 1 location
Atopic Dermatitis
The OXFORAD™ Study will determine how well an investigational drug works in treating people with moderate-to-severe eczema (atopic dermatitis).
- 132 views
- 23 Nov, 2020
- 1 location
Eczema Research Study
Looking for patients 18 years of age and older who have been diagnosed with eczema.
- 71 views
- 23 Nov, 2020
- 1 location
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
The purpose of this study is to compare the safety and effects, good or bad, of MSTT1041A versus placebo on patients with moderate to severe atopic dermatitis.
- 143 views
- 23 Nov, 2020
- 1 location
Studies for the Treatment of Atopic Dermatitis (eczema)
Studies for the Treatment of Atopic Dermatitis (eczema)
- 840 views
- 08 Nov, 2020
- 1 location
Acne, psoriasis, atopic dermatitis
Acne, psoriasis, atopic dermatitis
- 2006 views
- 25 Mar, 2021
- 1 location
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).
A 10-12 week study to evaluate an oral medication for itching related to eczema (atopic dermatitis).
- 564 views
- 08 Nov, 2020
- 1 location
Study of Ruxolitinib Cream in Children With Atopic Dermatitis
Open-label, BID application to all affected areas identified at BSLN for 4 weeks (maximum use trial (MUsT) period). The next 4 weeks (treatment extension period) will be applied BID to active lesions only for the next 4 weeks for a total treatment period of 8 weeks. Eligible participants will be …
- 0 views
- 21 Mar, 2022
- 16 locations